Manganese improves CD8+ T cell recruitment via cGAS-STING in hepatocellular carcinoma
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.113591 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Chunxue Fu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, Xinjiang, China; NHC Key Laboratory of Preven…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, CD8-Positive T-Lymphocytes, Manganese. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a major cause of cancer-related deaths worldwide. Chemotherapy using cisplatin, a drug that damages deoxyribonucleic acid (DNA), is not very effective in treating HCC due to its side effects and drug resistance. Manganese (Mn2+), a trace element, has been shown to enhance immune responses, but its ability to improve cisplatin-induced antitumor immunity in HCC remains unclear. The present study found that treatment with Mn2+ in combination with cisplatin promoted cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling activation and C-X-C motif chemokine ligand 10 (CXCL10) production in tumor and dendritic cells. CXCL10 is associated with CD8A levels, and its high expression is linked to better prognosis in patients with HCC. In addition, Mn2+ and cisplatin co-treatment enhanced the recruitment of CD8+ T cells through the CXCL10/CXCR3 axis. Similarly, in an orthotopic transplantation tumor model, STING activation, CD8+ T cell infiltration, and tumor cell killing levels were higher in the combined treatment group. The above findings suggest that utilizing Mn2+ in combination with cisplatin could be a potential treatment option for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, Xinjiang, China; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases, The First…
Zitieren
APA
Fu, C., Guo, H., Wang, M., Ni, C., Wu, X., Chen, X., Hou, J., & Wang, L. (2024). Manganese improves CD8+ T cell recruitment via cGAS-STING in hepatocellular carcinoma. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113591
Vancouver
Fu C, Guo H, Wang M, Ni C, Wu X, Chen X, et al. Manganese improves CD8+ T cell recruitment via cGAS-STING in hepatocellular carcinoma. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113591
BibTeX
@article{Fu2024,
author = {Fu, Chunxue and Guo, Hanrui and Wang, Meiling and Ni, Caiya and Wu, Xiangwei and Chen, Xueling and Hou, Jun and Wang, Lianghai},
title = {Manganese improves CD8+ T cell recruitment via cGAS-STING in hepatocellular carcinoma},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.113591}
}
EUVIMED